TENX Earnings

Quarterly EPS
$-0.19
Q3 2024
$-0.17
Q4 2024
$-0.28
Q1 2025
$-0.27
Q2 2025
$-0.40
Q3 2025
$-0.38
Q4 2025
$-0.35
Q1 2026
$-0.35
Q2 2026
Latest RevenueN/A
Latest Net Income-17803000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.350-17803000-29.6%
Q1 2026-$0.350-15716000-25.0%
Q4 2025-$0.380-15540000-123.5%
Q3 2025-$0.400-15804000-110.5%
Q2 2025-$0.270-10847000+85.2%
Q1 2025-$0.280-10408000+91.0%
Q4 2024-$0.170-6267000+98.4%
Q3 2024-$0.190-3961000+97.1%
Q2 2024-$1.830-3575000
Q1 2024-$3.120-3799000
Q4 2023-$10.650-3225926
Q3 2023-$6.610-1971975
Tenax Therapeutics (TENX) — Earnings